首 页   本刊简介  编委会  审稿专家  在线期刊  写作规范  广告合作  联系我们
您现在的位置:首页 => 在线期刊 => 2014年 10期 => 肝衰竭 =>格拉斯哥预后评分对HBV相关慢加..
格拉斯哥预后评分对HBV相关慢加急性肝衰竭患者死亡的预测价值
Predictive value of Glasgow Prognostic Score system for mortality in patients with acute-on-chronic liver failure associated with hepatitis B
文章发布日期:2014年09月12日  来源:  作者:李绍军, 程家喜, 鲁晓擘, 等  点击次数:2789次  下载次数:450次

调整字体大小:

(此处下载失败可以在在线预览处保存副本或者右键另存为)

【摘要】:目的探讨格拉斯哥预后评分(GPS)对HBV相关慢加急性肝衰竭(HBV-ACLF)患者死亡的预测价值。方法选取新疆医科大学第一附属医院2008年4月至2012年4月住院期间诊断为HBV-ACLF的患者437例,依据GPS评分对患者进行分组,比较不同GPS评分组的死亡比率。计量资料符合正态分布两组间比较采用t检验,三组及以上采用F检验;计数资料比较采用χ2检验。采用Cox生存回归筛选随访期间[30(5~825)d]患者死亡的的影响因素。结果HBV-ACLF患者随访期间病死率为680%(297/437)。GPS评分越高的分组住院期间消化道出血比例、肝性脑病比例、肝肾综合征比例和终末期肝病模型(MELD)就越高,且差异具有统计学意义(P值均<0.05)。Cox回归分析显示,肝性脑病(Ⅰ~Ⅱ vs 无肝性脑病: HR: 2520, 95%CI: 1.479~4293,P=0.001; Ⅲ~Ⅳ vs 无肝性脑病:HR: 3.678, 95%CI: 1.920~7.047, P<0.001),肝肾综合征(HR: 2.374, 95%CI: 1452~3881, P=0.001),消化道出血(HR: 1.616, 95%CI: 1.153~2.262,P=0.004),抗病毒治疗(HR: 0.668, 95%CI: 0.518~0862, P=0002),GPS评分(1 vs 0: HR: 2.055, 95%CI:1653~2702,P=0001; 2 vs 0:HR:4520, 95%CI:3288~6932, P=0007)和HBV-ACLF患者死亡密切相关。结论GPS评分对HBV-ACLF患者的短期和长期死亡风险预测作用较好,且高GPS评分为HBV-ACLF患者死亡的危险因素。
【Abstract】:ObjectiveTo assess the predictive value of Glasgow Prognostic Score (GPS) system for mortality in patients with acute-on-chronic liver failure associated with hepatitis B(HBV-ACLF). MethodsThe clinical data of 437 patients who were diagnosed with HBV-ACLF and admitted to the Department of Infectious Diseases, The First Affiliated Hospital of Xinjiang Medical University, from April 2008 to April 2012 were retrospectively evaluated. Patients were grouped according to their GPS scores, and the mortality rates were compared between GPS groups. Continuous data in normal distribution were compared by t test between two groups and by F-test between three or more groups. Comparison of categorical data was made by chi-square test. COX proportional hazards regression was performed to identify clinical variables associated with overall survival during the follow-up period [30 (5-825) d]. ResultsThe mortality rate of patients with HBV-ACLF was 68.0% (297 cases) during the follow-up period. The group with higher GPS scores had significantly increased proportions of individuals with gastrointestinal bleeding, hepatic encephalopathy, and hepatorenal syndrome and higher Model of End-Stage Liver Disease scores (P<0.05 across all variables). COX proportional hazards regression analysis revealed the risk factors closely associated with the mortality of patients with HBV-ACLF, which included hepatic encephalopathy (grade I-II vs absence of hepatic encephalopathy: hazard ratio, HR: 2520, 95% confidence interval, CI: 1.479-4.293, P=0.001; grade III-IV vs absence of hepatic encephalopathy: HR: 3678, 95% CI: 1.920-7.047, P<0.001), hepatorenal syndrome (HR: 2.374, 95% CI: 1.452-3.881, P=0.001), gastrointestinal bleeding (HR: 1.616, 95% CI: 1.153-2.262, P=0.004), antiviral therapy (HR: 0.668, 95% CI: 0.518-0.862, P=0.002) and the GPS (1 vs 0: HR: 2055,95%CI:1653-2702,P=0001; 2 vs 0: HR: 4520, 95%CI: 3288-6932, P=0007). ConclusionThe GPS system has a good predictive value for short- and long-term mortality in patients with HBV-ACLF. Elevated GPS is an independent risk factor for death in patients with chronic liver failure associated with hepatitis B.
【关键字】:格拉斯哥预后评分;肝炎病毒,乙型;肝功能衰竭;死亡
【Key words】:glasgow outcome scale; hepatitis B; liver failure; death
【引证本文】:

地址:长春市东民主大街519号《临床肝胆病杂志》编辑部 邮编:130061 电话:0431-88782542/3542
临床肝胆病杂志 版权所有 Copyright © 2009 - 2013 Lcgdbzz.org. All Rights Reserv 吉ICP备10000617号

吉公网安备 22010402000041号